BUSINESS CASE: Amatsigroup acquired by Eurofins, an other example of Xperts Council’s expertise
Eurofins announced on the 10th of July their purchase of Amatsigroup. The latter is one of the world’s leading Contract Development and Manufacturing Organizations.
Eurofins and Ekkio Capital, the former Amatsigroup majority shareholders, signed an exclusive agreement. The purchase should be completed in the next few months. This acquisition could reach 130 million euros. Xperts Council has been once again involved in this purchase, providing experts for the several funds interested.
Amatsigroup: an external growth with strong results
Xperts Council’s contribution
This acquisition is the outcome of a long preliminary research made by several funds and consulting firms with the support of Xperts Council.
Indeed, since the end of 2016, investment funds and consulting firms have called upon us to provide them with information on the pharmaceutical industry, and more precisely on the CDO and CMO markets for their due diligence.
Most of our clients were particularly keen in understanding local regulations, the consequences on the set up of laboratories, the value chain or the market segmentation.
But other important questions asked were: What factors can explain the amazing growth of Amatsi ? How does the supply chain work for a CDMO and what are the disruptive technologies for a CRO (Contract Research Organization) ?
How we helped
Our consultants quickly gathered a wide team of experts able to answer our clients’ questions. Most of them were former managers of the targeted company, or senior managers from competitors, which satisfied our clients.
As a result, we provided global and valuable knowledge on this fast growing niche market, as well as precise and decisive intelligence on the targeted company. Therefore, Xperts Council delivered all the insights required and met all its clients’ expectations.